Buy Stocks Easy | About Us
January 18, 2022
Buy Stocks Easy | Online Stocks

VLRX


Buy Valeritas Holdings, Inc. Stock (symbol: VLRX) Easy Online

Company Name: Valeritas Holdings, Inc.

Symbol: VLRX

Sector: Health Care

Industry: Medical/Dental Instruments

IPO: 2016

VLRX Current Share Price

Today's VLRX ( Valeritas Holdings, Inc. ) opening price: $0.9200

Yesterday's VLRX ( Valeritas Holdings, Inc. ) closing price: $1.6600

Valeritas Holdings, Inc. Stock ( symbol: VLRX ) Price Chart since IPO (2016):

12 Months Valeritas Holdings, Inc. Stock ( symbol: VLRX ) Price Chart

Popular Questions about Valeritas Holdings, Inc. Public Stock ( VLRX )

A: Valeritas Holdings, Inc. stock symbol (also called stock or share ticker) is VLRX

A: Valeritas Holdings, Inc. IPO (Initial Public Offering) took place on 2016

A: Valeritas Holdings, Inc.'s stock (VLRX symbol) price at ther IPO (initial Public Offering) was $0.9200

Q: Is VLRX stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Valeritas Holdings, Inc. stock (symbol: VLRX) at the beginning of 2019, at the opening share price of $0.4100, with a minimum of $200, by now your shares would be worth $97760 and your profit would be $97560 - SHOW ONLY IF PROFIT.

Buy Valeritas Holdings, Inc. Stock Easy Online

Valeritas Holdings, Inc. Stock Ticker Price Chart since IPO:





Valeritas Holdings, Inc. Stock Price Yesterday



 


Valeritas Holdings, Inc. Stock Price – Last Week




 


Valeritas Holdings, Inc. Stock Price – Last Month




 


Valeritas Holdings, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
    
VLRX
5 (100%) 1 vote            
        

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936883/0/en/Valeritas-Presents-Positive-h-Patch-Apomorphine-Study-Data-at-the-World-Congress-of-Neurology-WCN-2019.html
                            

                                
Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

                                
                                
BRIDGEWATER, N.J., Oct.  29, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932423/0/en/GLP-1-Analogue-Delivered-Robustly-via-Subcutaneous-Infusion-with-Valeritas-Proprietary-h-Patch-Wearable-Device-in-Preclinical-Study.html
                            

                                
GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary  h-Patch™ Wearable Device in Preclinical Study

                                
                                
- Company Plans to Explore Opportunities with Industry Partners Loo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/15/1929551/0/en/Valeritas-Presents-Positive-h-Patch-Apomorphine-Study-Data-at-Global-Experts-Meeting-on-Frontiers-in-Alzheimer-s-Disease-Dementia.html
                            

                                
Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

                                
                                
BRIDGEWATER, N.J., Oct.  15, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/08/1926354/0/en/Valeritas-Announces-Poster-Presentation-of-Preclinical-h-Patch-Apomorphine-Study-at-the-World-Congress-of-Neurology-WCN-2019.html
                            

                                
Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2019)

                                
                                
BRIDGEWATER, N.J., Oct.  08, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1923941/0/en/Valeritas-Reduces-its-Long-Term-Debt-Obligation-Nearly-60-by-Exchanging-25-0-Million-of-Debt-for-Series-B-Convertible-Preferred-Stock.html
                            

                                
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock

                                
                                
- Debt Exchange Expected to Save Approximately $8 Million in Cash I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/26/1921345/0/en/Valeritas-Announces-Participation-on-The-Cutting-Edge-of-Cannabinoid-Science-Panel-at-the-CBD-Expo-EAST-Conference.html
                            

                                
Valeritas Announces Participation on “The Cutting Edge of Cannabinoid Science” Panel at the CBD Expo EAST Conference

                                
                                
BRIDGEWATER, N.J., Sept.  26, 2019  (GLOBE NEWSWIRE) -- Valeritas H...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919781/0/en/Valeritas-Presents-Positive-h-Patch-CBD-Study-Data-at-CannMed-Conference.html
                            

                                
Valeritas Presents Positive h-Patch™ CBD Study Data at CannMed Conference

                                
                                
Study Shows Peak CBD Plasma Levels Obtained Using 7.5 Times Less CB...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/19/1917859/0/en/Valeritas-Announces-Presentation-of-Preclinical-h-Patch-CBD-Study-at-CannMed-Conference.html
                            

                                
Valeritas Announces Presentation of Preclinical h-Patch™ CBD Study at CannMed Conference

                                
                                
BRIDGEWATER, N.J., Sept.  19, 2019  (GLOBE NEWSWIRE) -- Valeritas H...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/20/1963494/0/en/Valeritas-Experiences-a-Temporary-Supply-Disruption-Resulting-in-Revised-Preliminary-Financial-Results-for-2019-Fourth-Quarter-and-Full-Year.html
                            

                                
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year

                                
                                
BRIDGEWATER, N.J., Dec.  20, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936883/0/en/Valeritas-Presents-Positive-h-Patch-Apomorphine-Study-Data-at-the-World-Congress-of-Neurology-WCN-2019.html
                            

                                
Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

                                
                                
BRIDGEWATER, N.J., Oct.  29, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932423/0/en/GLP-1-Analogue-Delivered-Robustly-via-Subcutaneous-Infusion-with-Valeritas-Proprietary-h-Patch-Wearable-Device-in-Preclinical-Study.html
                            

                                
GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary  h-Patch™ Wearable Device in Preclinical Study

                                
                                
- Company Plans to Explore Opportunities with Industry Partners Loo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/15/1929551/0/en/Valeritas-Presents-Positive-h-Patch-Apomorphine-Study-Data-at-Global-Experts-Meeting-on-Frontiers-in-Alzheimer-s-Disease-Dementia.html
                            

                                
Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

                                
                                
BRIDGEWATER, N.J., Oct.  15, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/08/1926354/0/en/Valeritas-Announces-Poster-Presentation-of-Preclinical-h-Patch-Apomorphine-Study-at-the-World-Congress-of-Neurology-WCN-2019.html
                            

                                
Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2019)

                                
                                
BRIDGEWATER, N.J., Oct.  08, 2019  (GLOBE NEWSWIRE) -- Valeritas Ho...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1923941/0/en/Valeritas-Reduces-its-Long-Term-Debt-Obligation-Nearly-60-by-Exchanging-25-0-Million-of-Debt-for-Series-B-Convertible-Preferred-Stock.html
                            

                                
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock

                                
                                
- Debt Exchange Expected to Save Approximately $8 Million in Cash I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/26/1921345/0/en/Valeritas-Announces-Participation-on-The-Cutting-Edge-of-Cannabinoid-Science-Panel-at-the-CBD-Expo-EAST-Conference.html
                            

                                
Valeritas Announces Participation on “The Cutting Edge of Cannabinoid Science” Panel at the CBD Expo EAST Conference

                                
                                
BRIDGEWATER, N.J., Sept.  26, 2019  (GLOBE NEWSWIRE) -- Valeritas H...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919781/0/en/Valeritas-Presents-Positive-h-Patch-CBD-Study-Data-at-CannMed-Conference.html
                            

                                
Valeritas Presents Positive h-Patch™ CBD Study Data at CannMed Conference

                                
                                
Study Shows Peak CBD Plasma Levels Obtained Using 7.5 Times Less CB...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.